Mesoporous nanocarriers for the loading and stabilization of 5-aminolevulinic acid
Source abstract
Abstract
Mesoporous nanoparticles bearing different surface functionalizations were proposed as host carrier for the loading and stabilization of 5-aminolevulinic acid: unmodified mesoporous silica nanoparticles exposing native silanols and aminopropyltriethoxysilane-grafted mesoporous silica nanoparticles exposing amino groups. The stability of 5-aminolevulinic acid at different steps of drug loading was monitored via electronic and vibrational spectroscopies. Unmodified mesoporous nanoparticles were found to be a host system ensuring the stability of 5-aminolevulinic acid and its availability as protoporphyrin IX precursor, whilst silica surface exposing amino groups was found to strongly favour the dimerization of 5-aminolevulinic acid, leading to the formation of the derived compound pyrazine-2,5-dipropionic acid which is considered to be the major ALA degradation product in aerated solutions, which is no longer active as precursor of protoporphyrin IX. This phenomenon is interpreted in terms of the basic character of amino-modified silica.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Porphyrin Metabolism and Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Adam C, Salomon G et al (2009) Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure. Eur Urol 55:1281–128810.1016/j.eururo.2009.02.027 ↗
2. Alev-Behmoaras T, Toulme J, Hélène C (1979) Quenching of tyrosine fluorescence by phosphate ions: a model study for protein-nucleic acid complexes. Photochem Photobiol 30:533–53910.1111/j.1751-1097.1979.tb07177.x ↗
3. Allison RR, Mota HC, Sibata CH (2004) Clinical PD/PDT in North America: an historical review. Photodiagn Photodyn Ther 1:263–27710.1016/S1572-1000(04)00084-5 ↗
4. Allison RR, Cuenca R et al (2005) PD/PDT for gynecological disease: a clinical review. Photodiagn Photodyn Ther 2:51–6310.1016/S1572-1000(05)00033-5 ↗
5. Ambrogi V, Perioli L, Marmottini F, Latterini L, Rossi C, Costantino U (2007) Mesoporous silicate MCM-41 containing organic ultraviolet ray absorbents: Preparation, photostability and in vitro release. J Phys Chem Solids 68:1173–117710.1016/j.jpcs.2007.02.033 ↗
6. Berlier G, Gastaldi L, Ugazio E, Miletto I, Iliade P, Sapino S (2013a) Stabilization of quercetin flavonoid in MCM-41 mesoporous silica: positive effect of surface functionalization. J Colloid Interface Sci 393:109–11810.1016/j.jcis.2012.10.073 ↗
7. Berlier G, Gastaldi L, Sapino S, Miletto I, Bottinelli E, Dichirio D, Ugazio E (2013b) MCM-41 as a useful vector for rutin topical formulation: Synthesis, formulation and testing. Int J Pharm 457:177–18610.1016/j.ijpharm.2013.09.018 ↗
8. Braschi I, Gatti G, Bisio C, Berlier G, Sacchetto V, Cossi M, Marchese L (2012) The role of silanols in the interactions between methyl tert-butyl ether and high-silica Faujasite Y: an infrared spectroscopy and computational model study. J Phys Chem C 116:6943–695210.1021/jp210605t ↗
9. Bunker A, Zerbe O, Schmid H, Burmeister G, Merkle HP, Gander B (2000) Degradation mechanism and stability of 5-aminolevulinic acid. J Pharm Sci 89(10):1335–134110.1002/1520-6017(200010)89:10<1335::AID-JPS11>3.0.CO;2-# ↗
10. Cairnduff F, Springer M, Hudson EJ, Ash DV, Brown SB (1994) Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69:605–60810.1038/bjc.1994.112 ↗
11. Chen JY, Peng Q, Jodl HI (2003) Infrared spectral comparison of 5-aminolevulinic acid and its hexyl ester. Spectrochim Acta Part A 59:2571–257610.1016/S1386-1425(03)00011-8 ↗
12. Collaud S, Juzeniene A, Moan J, Lange N (2004) On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem-Anti Cancer Agents 4:301–31610.2174/1568011043352984 ↗
13. Elfsson B, Wallin I, Eksborg S, Rudaeus K, Ros AM, Ehrsson H (1999) Stability of 5-aminolevulinic acid in aqueous solution. Eur J Pharm Sci 7:87–9110.1016/S0928-0987(98)00009-8 ↗
14. Eljamel MS, Goodman C, Moseley H (2008) ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci 23:361–36710.1007/s10103-007-0494-2 ↗
15. Faruki MdZ, Razzaque E, Bhuiyan MA (2013) Improvement of solubility of badly water soluble drug (Ibuprofen) by using surfactants and carriers. IJPSR 4:1569–1574
16. Gadmar OB, Moan J, Scheie E, Ma LW, Peng Q (2002) The stability of 5-aminolevulinic acid in solution. J Photochem Photobiol B Biol 67:187–19310.1016/S1011-1344(02)00278-6 ↗
17. Granick S, Mauzerall D (1958) Porphyrin biosynthesis in erythrocytes. J Biol Chem 232:1119–114010.1016/S0021-9258(19)77426-2 ↗
18. Grossman HB (2007) Improving the management of bladder cancer with. fluorescence cystoscopy. J Environ Pathol Toxicol Oncol 26:143–14710.1615/JEnvironPatholToxicolOncol.v26.i2.90 ↗
19. Hoda MR, Popken G (2009) Surgical outcomes of fluorescence-guided laparoscopic partial nephrectomy using 5-aminolevulinic acid-induced protoporphyrin IX. J Surg Res 154:220–22510.1016/j.jss.2008.12.027 ↗
20. Hryhorenko EA, Oseroff AR, Morgan J, Rittenhouse-Diakun K (1998) Antigen specific and nonspecific modulation of the immune response by aminolevulinic acid based photodynamic therapy. Immunopharmacology 40:231–24010.1016/S0162-3109(98)00047-2 ↗
21. Hunter GA, Ferreira GC (2011) Molecular enzymology of 5-aminolevulinate synthase, the gatekeeper of heme biosynthesis. Biochim Biophys Acta 1814:1467–147310.1016/j.bbapap.2010.12.015 ↗
22. Hunter GA, Rivera E, Ferreira GC (2005) Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate. Arch Biochem Biophys 437:128–13710.1016/j.abb.2005.03.007 ↗
23. Jeffes EW, McCullough JL et al (1997) Photodynamic therapy of actinic keratoses with topical 5-aminolaevulinic acid. Arch Dermatol 133:727–73210.1001/archderm.1997.03890420065007 ↗
24. Kennedy J, Pottier R, Pross D (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol, B 6:143–14810.1016/1011-1344(90)85083-9 ↗
25. Kozlova SA, Kirik SD (2010) Post-synthetic activation of silanol covering in the mesostructured silicate materials MCM-41 and SBA-15. Micropor Mesopor Mater 133:124–13310.1016/j.micromeso.2010.04.024 ↗
26. Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7:283–28910.1039/B712847A ↗
27. Kwon S, Singh RK, Perez RA, Abou Neel EA, Kim H-W, Chrzanowski W (2013) Silica based mesoporous nanoparticles for controlled drug delivery. J Tissue Eng 4:1–1910.1177/2041731413503357 ↗
28. Lam S (1994) Photodynamic therapy in lung cancer. Semin Oncol 21:15–19
29. Li X, Zou ZP, Hu L, Zhang WJ, Li W (2014) Apoptotic cell death induced by 5-aminolaevulinic acid-mediated photodynamic therapy of hypertrophic scar-derived fibroblasts. J Dermatolog Treat 25:428–43310.3109/09546634.2012.697987 ↗
30. Ma X, Qu Q, Zhao Y (2015) Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy. ACS Appl Mater Interfaces 7(20):10671–1067610.1021/acsami.5b03087 ↗
31. MacCarron PA, Donnelly RF, Woolfson AD, Zawislak A (2003) Photodynamic therapy of vulval intraepithelial neoplasia using bioadhesive patch-based delivery of aminolevulinic acid. Drug Deliv Syst Sci 3:59–64
32. MacCarron PA, Donnelly RF, Woolfson AD, Zawislak A, Price JH, Maxwell P (2004) Photodynamic treatment of lichen sclerosus and squamosus hyperplasia using sustained topical delivery of aminolaevulinic acid from a novel bioadhesive. Br J Dermatol 151(68):105–106
33. Mattheolabakis G, Rigas B, Constantinides PP (2012) Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. Nanomedicine 7:1577–159010.2217/nnm.12.128 ↗
34. McCarron PA, Donnelly RF, Andrews GP, Woolfson AD (2005) Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. J Pharmac Sci 94(8):1756–177110.1002/jps.20393 ↗
35. McCarron PA, Donnelly RF, Woolfson AD (2008) Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias. Pharm Res 25(4):812–82610.1007/s11095-007-9352-y ↗
36. Miletto I, Bottinelli E, Caputo G, Coluccia S, Gianotti E (2012) Bright photoluminescent hybrid mesostructured silica nanoparticles. Phys Chem Chem Phys 14:10015–1002110.1039/c2cp40975e ↗
37. Millon SR, Ostrander JH, Yazdanfar S, Brown JQ, Bender JE, Rajeha A, Ramanujam N (2010) Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes. J Biomed Opt 15:01800210.1117/1.3302811 ↗
38. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH (1998) Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 134:248–24910.1001/archderm.134.2.248 ↗
39. Mottier N, Jeanneret F (2011) Evaluation of two derivatization reagents for the determination by LC-MS/MS of ammonia in cigarette mainstream smoke. J Agric Food Chem 59:92–9710.1021/jf103772c ↗
40. Nokes B, Apel M, Jones C, Brown G, Lang JE (2013) Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications. J Surg Res 181:262–27110.1016/j.jss.2013.02.002 ↗
41. Novo M, Huttmann G, Diddens H (1995) Chemical instability of 5-aminolevulinic acid (ALA) in aqueous solution. Soc Photo-Opt Instrum Eng 2371:204–209
42. Novo M, Huttman G, Diddens H (1996) Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J Photochem Photobiol B Biol 34:143–14810.1016/1011-1344(96)07285-5 ↗
43. Pinto RC, Silva C, Martinho N, Rosado C (2013) Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives. Ther Deliv 4:251–26510.4155/tde.12.143 ↗
44. Popken G, Wetterauer U, Schultze-Seemann W (1999) Kidney-preserving tumour resection in renal cell carcinoma with photodynamic detection by 5-aminolaevulinic acid: preclinical and preliminary clinical results. BJU Int 83:578–58210.1046/j.1464-410x.1999.00977.x ↗
45. Radu DR, Lai C-Y, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 126:13216–1321710.1021/ja046275m ↗
46. Rosenholm JM, Lindén M (2008) Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J Contr Release 128:157–16410.1016/j.jconrel.2008.02.013 ↗
47. Rouquerol F, Rouquerol J, Sing K (1999) Adsorption by powders & porous solids. Academic Press, San Diego
48. Stables GI, Stringer MR, Robinson DJ, Ash DV (1997) Large patches of Bowen’s disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 136:957–96010.1111/j.1365-2133.1997.tb03944.x ↗
49. Szeimies R-M, Sassy T, Landthaler M (1994) Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 59:73–7610.1111/j.1751-1097.1994.tb05003.x ↗
50. Tataurova Y, Sealy MJ, Larsen RG, Larsen S (2012) Surface-selective solution NMR studies of functionalized zeolite nanoparticles. J Phys Chem Lett 3:425–42910.1021/jz201582d ↗
51. Tripathi R, Verma S, Easwari TS, Shukla VK (2014) Mesoporous silica nanoparticles for drug delivery and controlled release. Int J Pharm Res Scholars 3:214–234
52. Van den Akker JTHM, Iani V, Star WM, Sterenborg HJCM, Moan J (2000) Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: Differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72(5):681–68910.1562/0031-8655(2000)072<0681:TAOAAH>2.0.CO;2 ↗
53. Viseu TMR, Hungerford G, Coelho AF, Ferreira MIC (2003) Dye–host interactions for local effects recognition in homogeneous and nanostructured media. J Phys Chem B 107:13300–1331210.1021/jp030284k ↗
54. Yang S-J, Lin C-F, Kuo M-L, Tan C-T (2013) Photodynamic detection of oral cancers with high-performance chitosan-based nanoparticles. Biomacromolecules 14:3183–319110.1021/bm400820s ↗
55. Zhu C-L, Wang X-W, Lin Z-Z, Xie Z-H, Wang X-R (2014) Cell microenvironment stimuli responsive controlled release delivery systems based on mesoporous silica nanoparticles. J Food Drug Anal 22:18–2810.1016/j.jfda.2014.01.002 ↗